Where I see patients (2)
My reviews
Selected research
-
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma.
American journal of clinical dermatology
-
Proceedings of the seventh annual Women in Melanoma Conference.
Therapeutic advances in medical oncology
Clinical trials
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Defined as complete response (CR) or partial response (PR) by Response Evaluation Criteria in Solid Tumors (RECIST v1.1). The ORR at stages 1 and 2 will be estimated using the method of Whitehead, and the p-values for testing the ...
Recruiting
4.9